United States News Todas as matérias

Cue Biopharma (NASDAQ:CUE) shares gained after the company reported positive results from a mid-stage study evaluating CUE-221 as a treatment for hives.

Paramount Skydance (NASDAQ:PSKY) and Warner Bros. Discovery (NASDAQ:WBD) shares gained after reports that Paramount Skydance was advancing settlement discussions with California’s attorney general over the proposed merger.

Accenture (NYSE:ACN) shares rose after the company announced a partnership with AI lab Anthropic to support artificial intelligence model evaluation and testing.

Novo Nordisk (NYSE:NVO) shares declined after the company presented its strategic ambitions for 2030 ahead of its Capital Markets Day, including long-term pipeline and obesity market targets.

nVent Electric (NYSE:NVT) declared a regular quarterly cash dividend of $0.21 per ordinary share, payable on November 6, 2026, to shareholders of record as of October 23, 2026.

Cadeler (NYSE:CDLR) signed a memorandum of understanding with Vattenfall to develop next-generation offshore wind operations and maintenance solutions through Cadeler’s Nexra service platform.

Asian shares mostly moved higher on Monday as investors monitored developments ahead of an expected meeting between U.S. President Donald Trump and Chinese President Xi Jinping covering trade, artificial intelligence and geopolitical issues.

Brent crude and West Texas Intermediate oil prices declined to their lowest levels in about a week as traders responded to renewed hopes for a diplomatic solution to the Middle East conflict.

GRAIL (NASDAQ:GRAL) shares rose sharply after U.S. Food and Drug Administration staff reviewers reported no major concerns regarding the safety and analytical performance of the company’s Galleri blood test designed to detect multiple cancers.

XORTX Therapeutics (NASDAQ:XRTX) announced plans to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration in the fourth quarter of 2026 for its XRx-026 gout program using the XORLO formulation of oxypurinol.

Joby Aviation (NYSE:JOBY) announced that an aircraft equipped with its autonomy technology completed the first autonomous flight across the United States, covering 3,199 miles without control inputs from its onboard safety pilot.

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for Enhertu (trastuzumab deruxtecan) in the adjuvant treatment of adults with resected HER2-positive breast cancer.

Corcept Therapeutics (NASDAQ:CORT) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommending approval of relacorilant combined with nab-paclitaxel for patients with platinum-resistant ovarian cancer.

Permian Basin Royalty Trust (NYSE:PBT) declared a September 2026 cash distribution of $0.019593 per unit, totaling $913,228.22, payable on October 15, 2026, to unitholders of record as of September 30, 2026.

Philip Morris International (NYSE:PM) increased its regular quarterly dividend by 8.8% to $1.60 per share, representing an annualized dividend rate of $6.40 per share.

Chanson International Holding (NASDAQ:CHSN) reported net income of $0.8 million for the six months ended June 30, 2026, compared with a net loss of $1 million in the same period a year earlier.

Abeona Therapeutics (NASDAQ:ABEO) announced that Ultragenyx Pharmaceutical received U.S. Food and Drug Administration approval for FAYUVI (rebisufligene etisparvovec-hopf), a gene therapy for Sanfilippo syndrome type A.

Santacruz Silver Mining (NASDAQ:SCZM) acquired a 500-tonne-per-day milling facility in Bolivia to process ore from its wholly owned subsidiary San Lucas and support expansion of its third-party ore-sourcing business.

MISTRAS Group (NYSE:MG) agreed to be acquired by affiliates of H.I.G. Capital for $20.35 per share in cash, representing an enterprise value of approximately $866 million including outstanding debt.

BlossomHill Therapeutics (NASDAQ:BLSM) reported second quarter 2026 financial results and pipeline progress, highlighting its strengthened cash position following an upsized initial public offering.

The Cato Corporation (NYSE:CATO) plans to close approximately 70 additional underperforming stores during the third and fourth quarters of fiscal 2026, bringing total planned store closures for the year to about 120 locations.

Merck (NYSE:MRK) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommending KEYTRUDA (pembrolizumab) combined with Padcev (enfortumab vedotin-ejfv) for adults with resectable muscle-invasive bladder cancer.

Xenon Pharmaceuticals (NASDAQ:XENE) shares declined after the company temporarily paused new patient enrollment in clinical studies evaluating its drug candidate for major depression and bipolar depression.

Novo Nordisk (NYSE:NVO) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) recommending once-weekly Sogroya (somapacitan) for children in Europe with idiopathic short stature and persistent growth disturbance.